Clay Thorp

Director at PIPr Therapeutics.

Raised on PIPr Therapeutics filings

$1.5M

of $2.5M offered across 1 Form D filing

Form D filings: 1
Teammates: 3
Last filing: Nov 12, 2025

Company

PIPr Therapeutics

Biotech · Durham, NC

Preclinical metalloprotease inhibitor drugs

Preclinical metalloprotease inhibitor drugs

Investors: 3
Still open: $1M

Investors: 3
Sector: Biotech
HQ: Durham, NC

PIPr Therapeutics filings

PIPr Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Nov 12, 2025	Equity	$1.5M/ $2.5M	Form D

EquityFiled Nov 12, 2025Form D
$1.5M/ $2.5M

Works with

Also named on PIPr Therapeutics filings

Tyler DoveBy POA from Heather Madsen, CEO, Form D signerForm D signer Holden ThorpDirector Heather MadsenMs. Madsen is a director and the CEO of the issuer.